The Global Drug Infusion System Market, valued at USD 13.93 Billion in 2025, is projected to exhibit a CAGR of 9.1%, reaching USD 25.63 Billion by 2032.
Market growth is primarily driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, which require long-term and precise drug delivery solutions. The rising adoption of ambulatory infusion pumps, advancements in smart infusion technologies, and growing demand for home-based healthcare are further supporting the market expansion.
Additionally, continuous innovation in infusion system designs to enhance patient safety, minimize medication errors, and improve treatment efficiency—along with favourable reimbursement policies and increased hospital investments in advanced infusion infrastructure—are expected to propel the market growth over the forecast period.
Market Takeaways
Global Drug Infusion System Market Report Coverage
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/drug-infusion-system-market
|
Report Coverage |
Details |
|
Market Revenue in 2025 |
USD 13.93 Billion |
|
Estimated Value by 2032 |
USD 25.63 Billion |
|
Growth Rate |
Poised to exhibit a CAGR of 9.1% |
|
Historical Data |
2020-2024 |
|
Forecast Period |
2025–2032 |
|
Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
|
Growth Drivers |
|
|
Trends |
|
|
Opportunities |
|
|
Restraints & Challenges |
|
Market Dynamics
The global drug infusion system market is experiencing robust growth, driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders that require precise, continuous, and controlled drug delivery. The rising demand for home-based and ambulatory care, coupled with advancements in smart infusion technologies, is further propelling the market expansion. Integration of automation, wireless connectivity, and data-driven monitoring in infusion systems is enhancing treatment safety, accuracy, and efficiency, leading to higher adoption across hospitals, clinics, and home care settings. Moreover, favorable reimbursement policies, growing investments in healthcare infrastructure, and the widespread use of infusion therapy in oncology and critical care are strengthening the market outlook.
Leading medical device manufacturers are focusing on developing intelligent, programmable, and patient-centric infusion systems that minimize medication errors and support interoperability with electronic health records (EHRs). The introduction of next-generation infusion pumps with dose-error reduction software, remote monitoring capabilities, and enhanced cybersecurity features is transforming clinical workflows and improving patient safety. In addition, partnerships between healthcare providers, technology companies, and device manufacturers are accelerating innovation in digital infusion solutions, predictive maintenance, and integrated care models. The growing shift toward disposable and elastomeric infusion systems for oncology and pain management is also contributing to the market growth by offering cost-effective and user-friendly alternatives.
However, the market faces certain challenges, including high device costs, cybersecurity concerns, and risks associated with infusion-related errors due to inadequate user training. Regulatory complexities and interoperability limitations across digital health platforms further constrain widespread adoption, especially in emerging regions. Despite these challenges, the increasing adoption of smart and connected devices, expansion of telehealth-based infusion services, and rising demand for ambulatory and wearable infusion systems are expected to drive sustained market growth through 2032.
Market Trends
The market is witnessing the rapid adoption of smart infusion systems integrated with IoT and cloud technologies. These devices enable real-time monitoring, automated alerts, and data-driven insights to enhance dosing accuracy and patient safety. Connectivity with electronic health records (EHRs) and use of dose error reduction software (DERS) allow seamless clinical workflow integration, minimising medication errors and improving treatment efficiency.
In August 2022, Baxter received the USFDA 510(k) clearance for its Novum IQ SYR syringe infusion pump paired with Dose IQ Safety Software. This system integrates with hospital electronic medical records (EMRs) via Baxter’s IQ Enterprise Connectivity Suite, enabling advanced connectivity, centralised drug library management, and dose error reduction.
The market is shifting toward compact, lightweight, and wearable infusion devices designed for home and ambulatory use. These systems allow patients to receive continuous therapies—such as insulin, chemotherapy, or pain management—outside hospital settings, enhancing comfort and reducing healthcare costs. Advances in battery life, wireless connectivity, and user-friendly interfaces are driving the adoption of portable and wearable infusion pumps that support greater patient mobility and independence.
In May 2023, Eitan Medical launched Avoset, a connected ambulatory infusion system designed for post-acute and speciality infusion therapies. The device is compact, supports low flow rates, has long battery life, and enables remote monitoring of infusion data.
Market Opportunities
Medical institutions and home-infusion providers are increasingly interested in shifting from a capex model to opex or subscription-based models. Offering infusion hardware bundled with software, maintenance, analytics, remote support, and consumables could lock in recurring revenue, reduce upfront cost barriers for customers, and make advanced devices more accessible in lower-income settings.
In June 2023, MedOne Group decided to offer both short-term and long-term rental options for infusion pumps, providing customised equipment, access to the latest technology, and full-service maintenance and support. This approach thereby started to encourage healthcare providers to deliver high-quality patient care while saving money and improving flexibility.
With telehealth adoption accelerating, infusion therapy could be more tightly integrated into remote care models. This includes devices that allow clinicians to monitor infusions remotely, adjust dosing via networked control, track adherence via connected sensors, and offer post-discharge infusion oversight. Such capabilities can reduce hospital readmissions, improve safety, and support home-based care for chronic conditions.
According to a study published in May 2024 titled “A Novel and Low-Cost Cloud-Enabled IoT Integration for Sustainable Remote Intravenous Therapy Management,” a cloud-based IoT drug infusion system was developed to support remote patient care. By integrating microcontroller technologies with a robust IoT framework, the system enables secure, precise, and remotely monitored infusion operations, enhancing both the quality and safety of patient care.
Analyst View
Key Developments
Competitive Landscape
Drug Infusion System Market Segmentation
Regional Insights
Related Reports :